CLARUS VENTURES
Clarus Ventures is a life sciences venture capital firm founded by a team of accomplished investment professionals with extensive and complementary industry backgrounds which have enabled them to establish a long history of success in creating value. Their deep relationships with world thought leaders and decision makers allow this team to identify unique investment opportunities and shepherd them to maturity. Clarus augments its core expertise of investing in biopharmaceuticals and medical technology companies with the deep and diverse expertise of the team in research and development, commercialization, business development and operations management at the global level. Clarus has $1.2 billion of assets under management across two lifesciences dedicated funds
CLARUS VENTURES
Social Links:
Industry:
Biotechnology Financial Services Medical Device
Founded:
2005-01-01
Status:
Active
Contact:
888-756-8443
Technology used in webpage:
SPF Domain Not Resolving Microsoft Azure DNS Microsoft Microsoft Azure Classic ASP Microsoft Azure US East Region Proofpoint MarkMonitor DNS
Similar Organizations
Teal Ventures
Teal Ventures is a venture capital firm focused on early-stage investing in health technology.
Current Advisors List
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2018-09-19 | Galera Therapeutics | Clarus Ventures investment in Series C - Galera Therapeutics | 70 M USD |
2018-02-01 | Avrobio | Clarus Ventures investment in Series B - Avrobio | 60 M USD |
2017-10-17 | Forty Seven | Clarus Ventures investment in Series B - Forty Seven | 75 M USD |
2017-09-07 | Gritstone Bio | Clarus Ventures investment in Series B - Gritstone Bio | 93 M USD |
2017-02-01 | PATH | Clarus Ventures investment in Venture Round - PATH | 25 M USD |
2016-08-17 | Cleave Therapeutics | Clarus Ventures investment in Series B - Cleave Therapeutics | 25.95 M USD |
2016-08-02 | Avrobio | Clarus Ventures investment in Series A - Avrobio | 25 M USD |
2016-06-23 | Annexon Biosciences | Clarus Ventures investment in Series B - Annexon Biosciences | 44 M USD |
2016-06-02 | Flowonix | Clarus Ventures investment in Debt Financing - Flowonix | 5 M USD |
2016-05-02 | GrayBug | Clarus Ventures investment in Series B - GrayBug | 44.5 M USD |